|

Office Based Opioid Treatment Basic Information for Physicians About Buprenorphine

Office Based Opioid
Treatment

Basic Information for
Physicians About Buprenorphine

 

Federal Law

Code of Federal Regulations. Confidentiality of Alcohol and Drug Abuse
Patient Records. 42 CRF Part 2. Read
PDF File Document
.

Public Law 106-310, 106th Congress. Sec. 3502. Controlled
Substances Act, October 17, 2000. Full
Law


Basic Information About DATA:
On October 17, 2000 Title XXXV
of the Children’s Health Act of 2000 was enacted that permits the
prescribing of schedule III, IV or V opioid treatment drugs that are
approved by the FDA for maintenance or detoxification treatment.



Title
XXXV
. Physician Waiver Authority to Prescribe, Dispense Schedule
III-V Narcotic Drugs in the Treatment of Narcotic Addiction. An ammendment
to Section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)).
Full Law Entitled: The Drug Addiction Treatment Act of 2000 (DATA).
(Summary)

Buprenorphrine Physician
Locator
.

Drug Addiction Treatment Act

Food and Drug Administration

Subutex and Suboxone tablets
(buprenorphine hydrochloride and buprenorphine hydrochloride and naloxone hydrochloride)

FDA Talk Paper

Drug Label

Patient Leaflet

Physician Information

Information for Pharmacists

Questions and Answers

State
Information

Federation of State Medical Boards (FSMB)

Upon approval of buprenorphrine the states will have a period of time
in which to implement state law. The FSMB has been working to coordinate
these initiatives and has developed a protocol guidelines for state
medical boards.

FSMB Buprenorphrine Guidelines

NAMA’s Comments to FSMB
NAMA was asked to
comment on the guidelines established by the FSMBs and this is the
response.

 

Manuals and Other
Publications

Physicians’ Guide: Opioid Agonist Medical Maintenance
Treatment

Using Buprenorphine for Office Based Opioid
Treatment

A manual for using buprenorphrine in an
office based setting.(PDF file)

Methadone Medical Management
A manual for
treating long term stable methadone patients in an office based practice.
(PDF file)

OBOT Publications
Manuals, publications
and other OBOT resources.

Suboxone.Com
Basic Information for Physicians and Patients.

Training

American Society of Addiction Medicine
(ASAM)

American Academy of Addiction Psychiatry
(AAAP)

American Osteopathic Association (AOA)

American Psychiatric Association (APA)

American Medical Association (AMA)

 

Similar Posts

  • Get Ready for National Recovery Month in September

    Admin 04/09/2021

    Get Ready for National Recovery Month in September NAMA declares 2005 THE YEAR OF RECOVERY FOR METHADONE PATIENTS Methadone patients have never been allowed to think of themselves as in recovery. This year the National Alliance of Methadone is declaring Recovery Month “The Year of Recovery for Methadone Patients.” Read the President’s Proclamation Time to…

  • Tag: ADA

    Admin 12/09/2022

    DOJ publishes guidance on Opioid Use Disorder and the Americans with Disabilities Act April 15, 2022 “The opioid crisis poses an extraordinary challenge to communities throughout our country. The Department of Justice (the Department) has responded with a comprehensive approach prioritizing prevention, enforcement, and treatment. This includes enforcing the Americans with Disabilities Act (Ada), which…

  • Favorite Links

    Admin 10/26/2022

    Links Favorite Links National Alliance of Methadone Advocates Rokki’s Methadone List Bitch and Gripe Methadone Espanol Bulletin Board TexNAMA New Zealand Methadone Advocates Pagina del Gruppo SIMS (NAMA Materials in Italian) Brugerforeningen (NAMA Materials in Danish) Addiction Treatment Forum The Ibogaine Dossier American Society of Addiction Medicine Center for Substance Abuse Treatment CSAT Treatment Facility…

  • |

    Patient Success Stories in Outpatient Medication-Assisted Treatment (MAT)

    Admin 03/10/2026

    Substance use disorders, particularly opioid dependence, remain a major public health challenge worldwide. One of the most effective and evidence-based approaches to treating opioid addiction is Medication-Assisted Treatment (MAT). MAT combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders comprehensively. Outpatient MAT programs allow patients to receive treatment while continuing their…

  • |

    Orlaam(LAAM) Alert

    Admin 06/17/2021

    FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

  • The National Methadone Conference

    Admin 03/14/2023

    Sponsored by American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Saturday, April 12, 2003 Pre-Conference Session  NAMA offers special thanks to Mallinckrodt. We also wish to thank Haworth Press, Vista Pharmaceuticals, Bendiner Labs, NIDA, and CSAT without whose support the first Certified Methadone Advocate (CMA) Training Course would not…